A tecnologia de fabricação de bebidas lácteas envolve a mistura de leite e soro, podendo ser fermentada por bactérias do iogurte ou probióticas e adicionada de polpa de fruta e outros aditivos permitidos. O produto final deve conter bactérias lácticas viáveis em número adequado. Os objetivos deste trabalho foram desenvolver bebidas lácteas probióticas a partir das misturas leite-soro e estudar sua vida-de-prateleira. O efeito da composição da cultura probiótica (Lactobacillus delbrueckii subsp. bulgaricus, L. acidophilus, L. rhamnosus e Bifidobacterium animalis subsp. lactis em co-cultura com Streptococcus salivarius subsp. thermophilus) e o efeito do pH final da fermentação na cinética de acidificação, pós-acidificação e contagem de bactérias probióticas foram estudados em soro de queijo Minas frescal e em diferentes misturas leite-soro. Bebidas lácteas probióticas foram desenvolvidas a partir das diferentes misturas leite-soro e a vida-de-prateleira foi determinada ao longo de 28 dias de armazenamento do produto a 4°C. As características dos produtos foram seguidas pelas determinações físico-químicas, microbiológicas e sensoriais. O soro apresentou efeito positivo sobre a velocidade máxima das co-culturas estudadas, bem como as diferentes composições das co-culturas influenciaram o parâmetro estudado. Todas as culturas apresentaram contagens maiores em pH final de fermentação 4,5, quando comparadas às obtidas em pH 5,5. A co-cultura StLb foi a mais rápida a fermentar os diferentes meios estudados e, a StLr, a mais lenta. Com a adição de açúcar e de estabilizante, os parâmetros cinéticos mostraram comportamento diferenciado daqueles obtidos em misturas leite-soro. Nas bebidas lácteas, as contagens de B. lactis mantiveram-se acima do limite exigido pela legislação até 28 dias de armazenamento do produto refrigerado. A pós-acidificação, cor e reologia variaram durante o período de armazenamento, influenciando a análise sensorial, cujos atributos obtiveram maior aceitação em bebidas elaboradas com 10% de sólidos lácteos. Os resultados indicaram que a bebida láctea elaborada com a co-cultura StBl foi a melhor alternativa para desenvolvimento de uma bebida funcional com boas características sensoriais. / The technology of production of lactic beverages involves the mixture of milk fermented by yoghurt or probiotic bacteria and whey in appropriate proportions, and the addition of fruit pulp and other allowed additives. The final product should contain viable lactic bacteria in appropriate counts. The objective of this work was to develop a probiotic lactic beverage from milk-whey mixtures and to study its shelf-life. The effect of the composition of the probiotic culture (Lactobacillus delbrueckii ssp. bulgaricus, L. acidophilus, L. rhamnosus and Bifidobacterium animalis ssp. lactis in co-culture with Streptococcus salivarius subsp. thermophilus) and the effect of the pH of the end of fermentation in the acidification kinetics, post-acidification and counts of probiotic bacteria were studied in Minas frescal cheese whey and in different mixtures milk-whey. Probiotic lactic beverages were developed from different milk-whey mixtures and the shelf-life was determined along 28 days of storage of the product at 4°C. The characteristics of the products were followed by determination of post-acidification, total acidity, color, rheology, probiotic viability and sensorial analysis. Whey presented positive effect on maximum acidification rates of the studied co-cultures, as well as the different compositions of the co-cultures influenced the studied parameter. All cultures presented higher counts when fermentation was stopped at pH 4.5, when compared to pH 5.5. The co-culture StLb presented the fast acidification performance while StLr, the slowest. The addition of sucrose and stabilizer affected the acidification kinetic parameters. In probiotic lactic beverages, counts of B. lactis were higher than the limit required by the legislation until 28 days of cool storage of the product. The post-acidification, color and rheological parameters varied during shelf-life, influencing the sensorial analysis, whose attributes obtained higher acceptance in the elaborated beverage with 10% of total solids. The results indicated that the lactic beverage elaborated with the co-culture StBl was the best alternative for development of a functional lactic beverage with good sensorial characteristics.

As microalgas vêm sendo utilizadas na área ambiental nos processos de biomitigação de CO2, uma vez que o utilizam em seu metabolismo para produzirem biomassa celular, a qual pode ser utilizada para fins nutricional e comercial. Neste sentido, o presente trabalho teve como objetivo a obtenção de oligossacarídeos prebióticos oriundos de biomassa microalgal por meio de hidrólise fosfórica em diferentes condições moderadas de pH e termopressurização. Foi utilizada biomassa de um cultivo utilizado no sistema de tratamento de efluente gasoso de uma churrascaria de Curitiba, comparativamente com duas biomassas comerciais, Chlorella vulgaris e Spirulina platensis. Foram realizadas análises microscópicas e físico-químicas para a caracterização das biomassas, tais como umidade, cinzas, teor de carboidratos, lipídeos e proteínas. A partir da massa lipídica total foram realizadas transesterificações alcalinas e os resultados analisados por métodos cromatográficos, antes e após clarificação dos ésteres metílicos. A título de comparação inicial com as biomassas in natura, as biomassas passaram por pré-tratamentos: remoção dos lipídeos com organossolventes, purificação da parede celular com detergente SDS (Sódio Dodecil Sulfato) e recuperação do resíduo polimérico extraído pelo detergente. Estas biomassas derivadas bem como as integrais foram hidrolisadas em termopressurizador a 4,5 atm (156 oC), utilizando ácido fosfórico a pH 2,0 ou controles com água (solvólise). Adicionalmente foram realizados ensaios enzimáticos com α-amilase e β-1,3 glucanase nos oligossacarídeos resultantes dos hidrolisados fosfóricos das biomassas in natura. Com as três biomassas de microalgas in natura foi realizado planejamento fatorial 32, frente às variáveis ácido fosfórico (pH 2,5, 2,0, e 1,5) e pressão atmosférica (3 atm – 147 oC, 4,5 – 156 oC e 6,0 atm – 175 oC). Para todos os hidrolisados foram analisados pH após a hidrólise, teor de açúcar redutor e de açúcar total e perfil cromatográfico. Os oligossacarídeos obtidos foram utilizados como fonte de carbono para o cultivo de microrganismos probióticos, Bifidobacterium animalis e Lactobacillus casei, para avaliação do crescimento, pH e produção de ácidos graxos de cadeia curta (AGCC). Os resultados indicaram que apesar de ter sido inoculada uma cepa de C. vulgaris no sistema de fotobiorreatores de mitigação de CO 2 da churrascaria, não se instalou um cultivo puro e, portanto, foi denominado de mescla Devons. O componente majoritário para todas as biomassas foi proteína, sobretudo para S. platensis (59,5 %). As transesterificações alcalinas mostraram a eficiência no processo, indicando semelhança no perfil da cromatografia gasosa da mescla Devons e C. vulgaris. O tratamento com SDS mostrou maior eficiência na remoção de proteínas, sobretudo em S. platensis. As hidrólises das biomassas pré-tratadas mostraram maior teor de oligossacarídeos na amostra in natura para mescla Devons, deslipidificada e tratada com SDS para C. vulgaris e semelhança entre a in natura e os dois primeiros tratamentos para S. platensis. Os resultados dos ensaios enzimáticos indicaram predominância de oligossacarídeos oriundos de laminarina (β-1,3 glucana), portanto prebióticos e resistentes à ação amilásica do trato gastrointestinal (TGI) superior. Os resultados do planejamento fatorial mostraram que a biomassa in natura de S. platensis foi a que apresentou os melhores resultados de hidrólise em quantidade de açúcar liberado, seguida da biomassa de mescla Devons e C. vulgaris. As melhores condições de produção e pureza de oligossacarídeos foram próximas ao ponto central do planejamento fatorial. Os cultivos dos probióticos utilizando os hidrolisados fosfóricos permitiu o crescimento das baterias benéficas (Lactobacillus e Bifidobacterium), e diferenças no pH, bem como na produção de AGCC, sobretudo ácido lático, monitorado por cromatografia líquida. Portanto, este trabalho mostra que foram produzidos oligossacarídeos prebióticos a partir do tratamento fosfórico da biomassa de microalgas, resultando uma nova aplicação em potencial de tal biomassa formada a partir do CO2 e outros componentes voláteis presentes no efluente gasoso da churrascaria. / Microalgae have been utilized in the environmental area in CO2 biomitigation processes as they use it in their metabolism for the production of cellular biomass, which can then be utilized for nutritional and commercial purposes. Within this scope, the current research elected as the main objective, the obtention of nutraceutical oligosaccharides from microalgae biomasses through a phosphoric acid hydrolysis under different and moderated pH and thermopressurization conditions. One biomass, coming from a gaseous effluent treatment system from a steakhouse was compared to commercial biomasses, Chlorella vulgaris e Spirulina platensis. Microscopic and physicochemical analyses were carried for these biomasses characterization, namely moisture, ashes, carbohydrates, lipids and protein contents. Alkaline methyl transesterifications were realized in the total lipid fractions and then the corresponding products analyzed by chromatographic methods. As compared to the native biomasses, they were subjected to pretreatments: organic solvents removal of lipids, cell wall purification with detergent SDS (Sodium Dodecyl Sulphate) and recovery of polymeric molecules of the later extracts. These derived biomasses fractions, as well as the whole ones were partially or totally hydrolyzed with thermopressurization at 4.5 atm (156 °C) using diluted phosphoric acid at pH 2 or with water as controls (solvolysis). Enzyme assays were further performed with α- amylase and β-1,3 glucanase in the phosphoric acid hydrolyzed oligosaccharides from native biomasses. A 32 factorial design was carried out with the three samples of whole microalgae biomasses, considering the variables phosphoric acid pH (2.5, 2.0, e 1.5) and atmospheric pressure (3 atm – 147 oC, 4.5 – 156 oC and 6.0 atm – 175 o C). For all hydrolysates were analyzed pH after hydrolysis, total and reducing sugar contents and chromatographic profiles. The resulting oligosaccharide samples were offered as carbon source for the culture of probiotic microorganisms Bifidobacterium animalis e Lactobacillus casei for the evaluation of bacterial growth and short chain fatty acids (SCFAs) production. Overall results indicated that irrespective to the pure native of the C. vulgaris inoculum into the CO2 mitigation system of the steakhouse, a pure massive biomass did not result and hence the designation of Devons’ blend for. The major component of microalgae biomasses was protein, above all for S. platensis (59.5 %). Alkaline transesterification showed the efficiency of the process, indicating similarity among the methyl esters arising either from C. vulgaris or the Devons’ blend as analyzed by gas chromatography. SDS treatment was more efficient for protein removal in the case of S. platensis biomass. The pretreated biomasses once hydrolysed displayed higher oligosaccharide contents for the Devons’ blend native, C. vulgaris delipidified and SDS-treated sample as well some similarity between native and both pretreatments in the case of S. platensis. The enzymatic assay indicated predominance of laminarin oligosaccharides (β-1,3 glucan), therefore prebiotics are resistants to amylasic action in upper gastroinstestinal tract. The factorial design showed that the particular S. platensis native biomass led to the best result of hydrolysis to reducing simple and oligosaccharidic sugars, then decreasingly followed by the Devons’ blend and C. vulgaris and the best conditions for the production and purity of the oligosaccharides were close to the central point of the factorial design. Probiotic cultures from the phosphoric acid hydrolysates allowed the Lactobacillus and Bifidobacterium, beneficial bacteria growth, pH differences and short chain fatty acids production, above all, lactic acid, as monitored by high performance liquid chromatography. Therefore, this research indicated the feasibility of nutraceutical or prebiotic oligosaccharide production from microalgae biomasses, thus revealing a novel technological destination for these particular biomasses and fractions, once formed at the expense of CO2 and other volatile components from the gaseous effluent from a steakhouse.

O tratamento antimicrobiano pode destruir o equilíbrio da microbiota gastrintestinal, podendo induzir sintomas clínicos, principalmente a diarréia. A influência de Lactobacillus casei Shirota sobre a microbiota intestinal foi avaliada em um estudo prospectivo, randomizado, duplo-cego e controlado. Sessenta e três crianças hospitalizadas com idade de 2 a 14 anos, sob tratamento com antibióticos &#946;-lactâmicos, foram randomizadas para receber o leite fermentado por L. casei Shirota, 108-9 UFC/mL, ou o placebo, durante o tratamento antimicrobiano. As amostras de fezes foram colhidas antes da administração do leite fermentado, durante o tratamento antibiótico e uma semana após o término do tratamento com o antimicrobiano e a ingestão do leite fermentado. O número de L. casei Shirota aumentou significativamente (p<0,001) durante o período de ingestão do leite fermentado. Foi observado na microbiota do grupo que recebeu o placebo um aumento na contagem de Pseudomonas aeruginosa (p<0,05) e Clostridium sp (p<0,05), principalmente no último período da terapia antimicrobiana. A alteração da microbiota intestinal em decorrência do tratamento antibiótico foi constatada pela diminuição de acetato (p<0,05), butirato (p<0,05) e formato (p<0,05). Embora nenhuma criança deste estudo tenha apresentado diarréia, na avaliação geral, a microbiota daquelas que receberam o leite fermentado mostrou uma recuperação precoce da microbiota intestinal. Foi observado que a variação da contagem bacteriana realizada não foi significativa para as crianças do grupo que recebeu o leite fermentado, enquanto que no grupo placebo a contagem bacteriana ficou alterada, mostrando desequilíbrio da microbiota. Cerca de 50% das crianças ainda apresentaram L. casei Shirota nas fezes após uma semana da ingestão do leite fermentado. Este estudo mostrou que a ingestão do leite fermentado contendo L. casei Shirota promoveu um reequilíbrio mais rápido da microbiota intestinal quando comparada com a do grupo que ingeriu o placebo. / Antimicrobial treatment can destroy the balance of gastrointestinal microflora, which may induce clinical symptoms, mainly diarrhoea. The influence of Lactobacillus casei Shirota on the intestinal microflora was assessed in a prospective, randomised, double-blind controlled study. Sixty-three hospitalised children, with ages between 2 and 14 years, under treatment with &#946;-lactam antibiotics were randomised to receive milk fermented by L. casei Shirota, 108-9 CFU/mL, or placebo during the antimicrobial treatment. Stool samples were collected before the administration of fermented milk, during the antibiotic treatment, and one week after the end of treatment with the antimicrobial agent and the ingestion of fermented milk. The number of L. casei Shirota increased significantly (p<0.05) during the period in which fermented milk was ingested. An increase in the Pseudomonas aeruginosa (p<0.05) and Clostridium sp (p<0.05) count was observed in the microflora of the group that received placebo, mainly in the last period of antimicrobial therapy. The alteration of intestinal microflora as a result of antibiotic treatment was found by the reduction of acetate (p<0.05), butyrate (p<0.05) and formate (p<0.05). The variation in bacterial count proved not to be significant for the children under antimicrobial treatment who received fermented milk, while the placebo group showed imbalance of microflora with the result of the altered bacterial count. About 50% of the children still presented L. casei Shirota in their stools after interrupting the ingestion of fermented milk for one week. This study showed that ingestion of fermented milk containing L. casei Shirota promoted a much faster re-balance of the intestinal microflora when compared to the group that ingested a placebo.

A link between the gut and the brain has been proposed to influence psychiatric disorders. Probiotics have been suggested to modify the gut microbiota and thereby improve autism symptoms in children. Attention deficit hyperactivity disorder (ADHD) has high comorbidity with other neuropsychiatric diagnoses, including autism. This is a follow-up of the first study examining a synbiotic intervention in patients with ADHD (Skott et al., 2019). In the original study, 114 adults participated. In this study, 38 adults were evaluated. The aim was to examine if suggested improvements remained 18 months post treatment. Specifically, if reductions were detected in comorbid autism symptoms, emotional dysregulation or functional impairment. The endpoints were measured using questionnaires: Autism-Spectrum Quotient (AQ), Difficulties in Emotion Regulation Scale (DERS-16) and Weiss Functional Impairment Rating Scale (WFIRS). No Synbiotic2000-specific effect was detected. Synbiotic2000 and placebo improved emotion regulation and life skill-functioning equally well. More research is needed to draw reliable conclusions. / En koppling mellan magen och hjärnan har i studier antytts påverka psykiatriska tillstånd. Probiotika har föreslagits förändra mag- och tarmkanalens bakterieflora och därigenom förbättra psykiatriska symtom hos barn med autism. ADHD har hög komorbiditet med andra neuropsykiatriska diagnoser, däribland autism. Detta är en långtidsuppföljning av RCT-studien som var först med att undersöka en synbiotika-intervention hos patienter med ADHD (Skott et al., 2019). I uppföljningen undersöktes 38 av de 114 vuxna som deltagit i originalstudien. Syftet var att undersöka om indikationerna till förbättring höll i sig 18 månader efter studieavslutet. Frågeställningen var om reduktion i komorbida autismsymtom, svårigheter med emotionsreglering eller funktionsnedsättning kunde identifieras. Detta undersöktes genom självskattningsskalor: Autism-Spectrum Quotient (AQ), Difficulties in Emotion Regulation Scale (DERS-16) och Weiss Functional Impairment Rating Scale (WFIRS). Ingen behandlingsspecifik effekt detekterades. Förbättringar av samma grad identifierades av Synbiotic2000 och placebo, utifrån emotionsreglering samt delskalan färdigheter. Mer forskning på området krävs för att möjliggöra tillförlitliga slutsatser. / BAMBA (Behandla Adhd med MagBakterier)

This Diploma thesis deals with preparation of probiotic cultures Lactobacillus acidophilus, Lactobacillus casei and Bifidobacterium breve enriched with prebiotics meant for application in baby food products. Natural extracts from matcha, moringa, young beat, young barley, chlorella and spirulina were selected as prebiotics. The theoretical part is focused on probiotic bacteria, their biological effects and their effects on the child´s body. The experimental part deals with the cultivation of probiotic bacteria with plant extracts, monitoring their viability and stabilization in an encapsulated form. Mixtures of probiotic cells with prebiotics were encapsulated into alginate particles to increase stability. Some of the alginate particles were processed by freeze drying. Mixtures of probiotic cultures with plant extracts were subjected to model human digestion by the action of model digestive juices in unencapsulated, encapsulated and lyophilized form. Selected extracts of plant materials were characterized in terms of amount of total and reducing sugars, total phenolic substances, individual phenolic substances and antioxidant activity. Further, two baby commercial dietary supplements containing probiotics were selected, which were characterized in terms of cell number and viability. Probiotic products were also subjected to model digestion.

Currently, there is a growing interest in the use of probiotic products, and there are many of them in the market. With the growing interest, greater emphasis is placed on the identification of declared probiotic microorganisms. Precise identification of microbial composition is often a difficult task and it requires more advanced methods especially in the field of molecular diagnostics. The diploma thesis was focused on the verification of the presence od declared probiotic microorganisms in probiotic food supplements GS Laktobacily Forte 21, Biopron 9 Premium and Linex® Forte. DNA was isolated from the complex matrices by phenol extraction, commercial kit and magnetic carriers F79/L3-PLL in the quality suitable for PCR. Subsequently, the isolated DNA was amplified by real-time polymerase chain reaction using genus- and species-specific primers. The specific PCR product was subjected to agarose gel electrophoresis, whereas species identification was not always in compliance with the data declared by producers. The next part of the thesis was focused on polymerase chain reaction with high-resolution melting analysis to distinguish bacterial strains belonging to the Lactobacillus group and to identify probiotic microorganisms present in the complex matrices of the probiotic food supplements. Eight primer sets were tested (V1F HRM a V1R-HRM, CHAU-V3F a CHAU-V3R, CHAU-V6F a CHAU-V6R, LAC2 a LAC4, LAC1 a LAC2, P1V1 a P2V1, poxcDNAFw a poxPromRVC, poxcDNAFw a poxPromRVT). Three primer pairs (V1F HRM a V1R-HRM, poxcDNAFw a poxPromRVC, poxcDNAFw a poxPromRVT) were evaluated as the most suitable for distinguishing Lactobacillus bacterial strains.

The aim of present work is cultivation of probiotic bacteria L. acidophilus, B. breve and B. longum in such a way that the culture forms cells clusters or comprehensive biofilm on the variety of free carriers. Biofilm formation of L. acidophilus on the silica from point of view bile and acid tolerance in gastrointestinal tract was studied. While the number of living cells in planktonic form (planktonic form) at pH 1 fell by 30 %, the viability of the biofilm cells was maintained to 90 % under the same environmental conditions. The biofilm culture showed also the protection against environment contained bile. Furthermore, the possibilities of drying procedures of biofilm cultures used as commercial technologies in pharmaceutical industry were studied. The comparison of freeze-drying and fluidization bed drying showed, that freeze-drying is more suitable method, which is able to achieve higher amount of viable cells after drying than fluidization bed drying. The effectivity of freeze-drying method is dependent on the selection of suitable cryprotective medium. In this case, about 90 % higher viability after freeze drying was achieved in comparison with fluidization bed drying. Finally, the industrial processing of probiotic strains into the solid dosage form was studied. Tablets should be produced at hardness between 70 and 90 N and water activity of tablet mixture can be maintained below 0.3. Consequently, the drying step of the tablets in a hermetically closed space with at least 10 % of silica gel must be ensured. Thereafter, the tablets contain (5.4 ± 0.7)109 viable cells after 6 months of drying process. Capsule production technology has no significant effect on the cell‘s viability during production. The triplex blistering foil for primary blistering of probiotic capsules was chosen. The triplex foil, which has low values of water vapour transition rate (0.07 g H2O / (m2 × day) and oxygen transition rate (0.01 cm3/m2 × day), was chosen. Other studied blistering foils commonly used in the pharmaceutical industry are not suitable for long storage of solid dosage forms contained probiotics.

Although strong protective immune response is essential for preventing invasion by pathogens, equivalent responses against antigens originating from commensal bacteria can lead to chronic inflammatory diseases, such as inflammatory bowel disease (IBD). Manipulating the mucosal immune responses with microbial antigens might be an excellent tool to IBD therapy or prevention. Our aim was to gain some insight into the regulation of the intestinal inflammation and to isolate bacterial immunomodulatory components that could be used in intestinal inflammation therapy and prevention. One particular mechanism of how healthy colon tissue regulates the inflammation during acute experimental colitis is through modulation of bioavailability of glucocorticoids (GCs) in gut mucosa. Here, we show that intestinal inflammation changes the local GC metabolism, which ultimately leads to decrease in inflammatory readiness of cells in the gut mucosa and in mesenteric lymph nodes. This pre-receptor regulation of GC function could represent an important homeostatic function of the gut mucosa. The actual triggers of intestinal inflammation in IBD seem to be either microbial dysbiosis or microbes with special "pathogenic" abilities, which both could be rectified by feeding with probiotics. Here, we report that oral feeding with live...

Although strong protective immune response is essential for preventing invasion by pathogens, equivalent responses against antigens originating from commensal bacteria can lead to chronic inflammatory diseases, such as inflammatory bowel disease (IBD). Manipulating the mucosal immune responses with microbial antigens might be an excellent tool to IBD therapy or prevention. Our aim was to gain some insight into the regulation of the intestinal inflammation and to isolate bacterial immunomodulatory components that could be used in intestinal inflammation therapy and prevention. One particular mechanism of how healthy colon tissue regulates the inflammation during acute experimental colitis is through modulation of bioavailability of glucocorticoids (GCs) in gut mucosa. Here, we show that intestinal inflammation changes the local GC metabolism, which ultimately leads to decrease in inflammatory readiness of cells in the gut mucosa and in mesenteric lymph nodes. This pre-receptor regulation of GC function could represent an important homeostatic function of the gut mucosa. The actual triggers of intestinal inflammation in IBD seem to be either microbial dysbiosis or microbes with special "pathogenic" abilities, which both could be rectified by feeding with probiotics. Here, we report that oral feeding with live...

La sclérose latérale amyotrophique (SLA) est une maladie neurodégénérative incurable partageant des mécanismes pathogéniques avec la démence frontotemporale (DFT). Elle est caractérisée par la dégénérescence sélective des neurones moteurs de la moelle épinière et du cerveau. Depuis les 25 dernières années, plus de 20 gènes ont été associés avec ces maladies, incluant FUS, C9ORF72 et TARDBP. Cependant, les liens entre la pathologie, le stade de la maladie et les mécanismes cellulaires demeurent incertains, mais semblent être multifactoriels. Bien que la SLA soit principalement considérée comme une maladie affectant le système nerveux, plusieurs d’observations suggèrent que des signaux périphériques, incluant ceux du tractus gastro-intestinal et de son microbiome, pourraient influencer la progression de la maladie. Récemment, de nouvelles études font état de perturbations du microbiome, appelé dysbiose, de la bioénergétique mitochondriale et de la composition lipidiques dans la SLA. Toutefois, il y a un manque considérable de compréhension de l’effet de ces perturbations sur la pathogenèse de la SLA. Une dysbiose a également été identifiée dans d’autres maladies neurodégénératives, telles que la maladie d’Alzheimer (MA) et la maladie d’Huntington (MH). En utilisant l’organisme modèle Caenorhabditis elegans, nous avons identifié une souche probiotique, Lacticaseibacillus rhamnosus HA-114, ayant des propriétés neuroprotectives dans différents modèles de SLA et de MH. Dans la première partie de cette thèse, nous avons démontrés que la neuroprotection conférée par L. rhamnosus HA-114 est unique par rapport aux autres souches de L. rhamnosus et réside dans son contenu en acide gras. Ces effets bénéfiques requièrent acdh-1/ACADSB, kat-1/ACAT1 and elo-6/ELOVL3/6, gènes impliqués dans le métabolisme des lipides et la β-oxydation mitochondriale. De plus, HA-114 retarde l’apparition des symptômes et réduit la neurodégénérescence chez la souris SOD1G93A. Nos résultats suggèrent que des perturbations du métabolisme des lipides contribuent à la neurodégénérescence et que HA-114 restaure l’homéostasie lipidique et énergétique via la β-oxydation mitochondriale. Dans la seconde partie de cette thèse, nous avons utilisé le C. elegans et avons caractérisé l’orthologue de CHCHD10, har-1, dans plusieurs essais afin d’étudier son implication dans la SLA et la DFT. CHCHD10 code pour une protéine impliquée dans la maintenance de la morphologie mitochondriale et la phosphorylation oxydative. Des mutations dans ce gène ont récemment été liées à la SLA. Nous avons caractérisé deux allèles distincts : une délétion de 260 pb (gk3124) et une mutation ponctuelle (ad2155). Les mutants har-1(gk3124) et har-1(ad2155) développent une paralysie, une dégénérescence des neurones GABAergiques et une altération de la santé mitochondriale. Le pioglitazone et le 2,4-thiazolidinedione, deux composés régulant la santé mitochondriale, restaurent plusieurs phénotypes associés à la SLA chez les mutants har-1. De plus, L. rhamnosus HA-114 a également des effets similaires sur ces souches. Ces résultats semblent confirmer un lien entre le microbiome et la SLA et pourraient ouvrir la voie à de futures thérapies via la modulation de l’environnement intestinal. De plus, découvrir les mécanismes impliqués dans cette neuroprotection permettrait sans doute la découverte de nouveaux gènes et de biomolécules actives ayant la capacité de moduler la neurodégénérescence, ouvrant la voie à l’utilisation de nouveaux médicaments. / Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative disease sharing pathological pathways with frontotemporal dementia (FTD). It is characterized by the selective degeneration of lower and upper motor neurons in the spinal cord and cerebral cortex. Over the last 25 years, more than 20 genes have been associated with these diseases, including FUS, C9ORF72 and TARDBP. Despite over a century of medical investigation, the links between pathology, disease stage and cellular mechanisms are still unclear, but may be multifactorial involving unresolved gene-environment interactions. While ALS is primarily considered a central nervous system disease, emerging evidence suggests that peripheral signals, including those from the gastrointestinal tract and gut microbiota, may be involved in ALS progression. Over the last year, new evidence showed perturbations in microbiota (called dysbiosis), mitochondrial bioenergetics, and in lipid composition in ALS. However, there is a considerable lack of understanding of the effect of these perturbations in ALS pathogenesis. Interestingly, dysbiosis has also been linked to other neurological conditions like Alzheimer’s disease (AD) and Huntington’s disease (HD). Using the model organism Caenorhabditis elegans, we discovered a probiotic bacterial strain, Lacticaseibacillus rhamnosus HA-114, with neuroprotective properties in models of ALS and HD. In the first part of this thesis, we demonstrated that neuroprotection from L. rhamnosus HA-114 is unique from other L. rhamnosus strains, and resides in its fatty acid content. Neuroprotection by L. rhamnosus HA-114 requires acdh-1/ACADSB, kat-1/ACAT1 and elo-6/ELOVL3/6, which are key fatty acid metabolism and mitochondrial β-oxidation genes. Moreover, L. rhamnosus HA-114 delayed disease onset and suppressed motor neuron degeneration in an aggressive mouse model of ALS. Our data suggest that disrupted lipid metabolism contributes to neurodegeneration and that dietary intervention with L. rhamnosus HA-114 restores lipid homeostasis and energy balance through mitochondrial β-oxidation. In the second part of this thesis, we used C. elegans and characterized the CHCHD10 orthologue har-1, in a number of behavioral assays, to learn more about the biological role of this gene and its implication in ALS-FTD pathogenesis. CHCHD10 is a widely expressed gene coding for a mitochondrial protein with a potential role in cristae morphology maintenance and/or oxidative phosphorylation with mutations recently associated with ALS. We characterized two distinct alleles: a deletion of 260 bp (gk3124) and a point mutation (ad2155). Both har-1 (gk3124) and har-1 (ad2155) worms display age-dependent motility defects leading to paralysis, degeneration of GABAergic neurons and altered mitochondrial health. The small molecules, pioglitazone and 2,4-thiazolidinedione, with known neuroprotective activity, and also shown to regulate mitochondrial health, suppressed several har-1 phenotypes. Moreover, dietary supplementation of L. rhamnosus HA-114 improved several ALS-related phenotypes in these har-1 mutants. These findings may confirm a link between microbiota and ALS and can lead to future therapies, through the modulation of the intestinal environment. L. rhamnosus HA-114 is suitable for human consumption opening the possibility of modifying disease progression by dietary intervention. Furthermore, uncovering the complete neuroprotection pathway may give us insights into new genes and bioactive molecules able to modulate neurodegeneration, thus opening the door to new therapeutic approaches.